Source: Richard Craver, WINSTON-SALEM JOURNAL, 5/9/19



The increasingly heated competition between makers of the two top-selling U.S. electronic cigarettes has extended into the public comments arena. The Food and Drug Administration recently accepted comments as part of the regulatory process for its proposal to heighten e-cig regulations. Juul Labs Inc., manufacturer of No. 1 e-cig brand Juul with a 74.6% market share, has drawn the main focus of FDA regulators, in particular former commissioner Dr. Scott Gottlieb, for the product’s design and flavor appeal to youths.

For more of this story, click here.